Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Lymphoid 3

Conditions

Lymphoma, Large B-Cell, Diffuse 97Leukemia, Lymphocytic, Chronic, B-Cell 88Lymphoma, Follicular 81Lymphoma 62Lymphoma, Mantle-Cell 59Lymphoma, B-Cell, Marginal Zone 47Lymphoma, Non-Hodgkin 46Recurrence 35Lymphoma, B-Cell 24Leukemia 20Waldenstrom Macroglobulinemia 18Hodgkin Disease 18Lymphoma, T-Cell, Peripheral 16Burkitt Lymphoma 14Lymphoma, T-Cell, Cutaneous 12Lymphoma, T-Cell 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Sezary Syndrome 10Mycosis Fungoides 10Multiple Myeloma 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Large-Cell, Anaplastic 9Immunoblastic Lymphadenopathy 8Lymphoma, Large-Cell, Immunoblastic 7Intraocular Lymphoma 7Neoplasms 6Lymphoma, Extranodal NK-T-Cell 6Leukemia, B-Cell 6Leukemia, Hairy Cell 5Leukemia-Lymphoma, Adult T-Cell 4

Interventions

Cyclophosphamide 73fludarabine phosphate 42Filgrastim 38Peripheral Blood Stem Cell Transplantation 35Radiotherapy 33Cyclosporine 32Busulfan 32Mycophenolic Acid 30Etoposide 29Antilymphocyte Serum 28Whole-Body Irradiation 26Methotrexate 25Melphalan 21Methylprednisolone 20Rituximab 19Vincristine 17Tacrolimus 17Cytarabine 17Cord Blood Stem Cell Transplantation 17Doxorubicin 14Prednisone 13Thiotepa 10Granulocyte Colony-Stimulating Factor 9Leucovorin 7Carboplatin 7fludarabine 6aldesleukin 6sargramostim 5Sirolimus 5Psychiatric Rehabilitation 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Dendritic Cell Sarcoma, Interdigitating × Lenalidomide × Lymphoid × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

NCT03003520 2023-05-22

A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma

Celgene

Phase 2 Completed
46 enrolled 20 charts
LymphoidSarcoma

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT04113226 2023-02-08

Relyage

Centre Hospitalier Universitaire, Amiens

Phase 2 Unknown
114 enrolled
LymphoidSarcoma

Recurrence, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡